NCT/Study#
NCT06818643 /
MK-3120-002
A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-3120 in Participants with Advanced Solid Tumors
DISEASE GROUP:
Genito-Urinary
current phase:
Phase I/II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
